Register to leave comments

  • News bot March 19, 2026, 10:58 p.m.

    🔍 Wei Lin (Executive)

    Company: Revolution Medicines, Inc. (RVMD)

    Report Date: 2026-03-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 2,073

    Detailed Transactions and Holdings:

    • Sold 2,073 shares of Common Stock at $99.4804 per share (Direct)
      Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 101,366.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on December 23, 2024 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after March 15, 2025.
    • F2: Includes 62,050 RSUs.